Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:40 pm Purchase | 2024-09-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 5,660,866 9.900% | 1,493,264 (+35.83%) | Filing History |
| 2024-11-08 11:54 am Purchase | 2024-09-30 | 13G | ELEVATION ONCOLOGY INC ELEV | Farallon Capital Partners, L.P. | 3,527,482 6.000% | 427,482 (+13.79%) | Filing History |
| 2024-11-07 09:56 am Purchase | 2024-09-30 | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners, L.P. | 8,208,123 9.900% | 4,102,370 (+99.92%) | Filing History |
| 2024-11-06 6:32 pm Purchase | 2024-09-30 | 13G | SAVARA INC SVRA | Farallon Capital Partners, L.P. | 17,762,533 9.990% | 3,435,622 (+23.98%) | Filing History |
| 2024-11-06 5:06 pm Sale | 2024-09-30 | 13G | SWIFTMERGE ACQUISITION CORP CL IVCP | Farallon Capital Partners, L.P. | 471,366 9.900% | -53,634 (-10.22%) | Filing History |
| 2024-10-16 4:35 pm Purchase | 2024-10-09 | 13D | SQUARESPACE INC SQSP | Farallon Capital Partners, L.P. | 5,600,000 6.100% | 5,600,000 (New Position) | Filing History |
| 2024-05-17 4:58 pm Purchase | 2024-05-09 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Farallon Capital Partners, L.P. | 4,391,941 9.100% | 4,391,941 (New Position) | Filing History |
| 2024-05-08 4:11 pm Purchase | 2024-05-06 | 13D | EXELIXIS INC EXEL | Farallon Capital Partners, L.P. | 26,769,500 9.200% | 909,500 (+3.52%) | Filing History |
| 2024-02-14 09:33 am Purchase | 2023-12-31 | 13G | FORTE BIOSCIENCES FBRX | Farallon Capital Partners, L.P. | 151,740 9.900% | 235 (+0.16%) | Filing History |
| 2024-02-12 5:11 pm Sale | 2023-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | Farallon Capital Partners, L.P. | 6,750,204 4.100% | -12,276 (-0.18%) | Filing History |
| 2024-02-12 3:38 pm Sale | 2023-12-31 | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners, L.P. | 4,105,753 5.000% | -7,716 (-0.19%) | Filing History |
| 2024-02-08 11:39 am Purchase | 2023-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 4,167,602 7.500% | 206,000 (+5.20%) | Filing History |
| 2024-02-06 10:16 am Purchase | 2023-12-31 | 13G | ARAMARK ARMK | Farallon Capital Partners, L.P. | 16,899,254 6.400% | 1,518,185 (+9.87%) | Filing History |
| 2024-02-05 5:28 pm Unchanged | 2024-02-01 | 13D | CAZOO GROUP LTD OCT 2023 CZOOF | Farallon Capital Partners, L.P. | 714,240 14.600% | 0 (Unchanged) | Filing History |
| 2024-02-05 11:22 am Sale | 2023-12-31 | 13G | SWIFTMERGE ACQUISITION CORP CL IVCP | Farallon Capital Partners, L.P. | 525,000 9.000% | -1,680,000 (-76.19%) | Filing History |
| 2024-02-02 09:19 am Purchase | 2023-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Farallon Capital Partners, L.P. | 5,765,109 9.990% | 710,007 (+14.05%) | Filing History |
| 2024-02-01 3:50 pm Purchase | 2023-12-31 | 13G | SAVARA INC SVRA | Farallon Capital Partners, L.P. | 14,326,911 9.990% | 2,794,289 (+24.23%) | Filing History |
| 2024-01-30 1:38 pm Sale | 2023-12-31 | 13G | BERENSON ACQUISITION CORP I CL BACA | Farallon Capital Partners, L.P. | 413,113 9.900% | -2,249,387 (-84.48%) | Filing History |
| 2024-01-30 11:23 am Purchase | 2023-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Farallon Capital Partners, L.P. | 2,205,990 9.990% | 788,073 (+55.58%) | Filing History |
| 2024-01-26 09:11 am Purchase | 2023-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Partners, L.P. | 2,025,000 9.600% | 475,000 (+30.65%) | Filing History |